Skip to main content

Crohn's Disease - Acute News (Page 3)

FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira

Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a p...

FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade

INCHEON, Korea – April 24, 2017 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar referencing Rem...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease

Related drug support groups

prednisone, metronidazole, Humira, ciprofloxacin, hydrocortisone, betamethasone, cortisone, Stelara, Remicade, view more... prednisolone, dexamethasone, adalimumab, budesonide, ustekinumab, Cimzia